Tirzepatide Tirzepatide is a dual agonist that targets both the glucose-dependent insulinotropic polypeptide (GIP) and the GLP-1 receptor
Zinman B, Bhosekar V, Busch R et al (2019) Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial
Semaglutide: GLP-1 receptor agonist What semaglutide is: GLP-1 (glucagon-like peptide-1) receptor agonist FDA approved for weight loss (Wegovy) Also approved for diabetes (Ozempic) Weekly injection Well-established safety profile Most popular weight loss peptide How GLP-1 works: Mimics natural GLP-1 hormone Increases insulin secretion (glucose-dependent) Suppresses glucagon Slows gastric emptying (moderate) Reduces appetite via brain centers Increases satiety Semaglutide's benefits: 10-15% average body weight loss Improved glucose control Cardiovascular benefits Reduced food cravings Better metabolic health Established track record See our peptides for weight loss , best peptides for weight loss , semaglutide dosage calculator , semaglutide vs tirzepatide , and best peptide stack for weight loss

18.4 When to Seek Medical Attention Immediate medical consultation is necessary if severe symptoms occur, including: Persistent abdominal pain Signs of allergic reaction Severe hypoglycemia Visual disturbances Sematrinity Pen Injection, Semaglutide FAQ Which brand of semaglutide is best for weight loss
Learn more about Express Scripts Pharmacy Manage your medication on-the-go